Artificial Womb Research Rapidly Advances As Birth Rate Plummets

Written by coreysdigs.com on October 24, 2022. Posted in Current News

The worldwide mRNA injection rollout has been an effective strategy for the globalists’ long-held depopulation agenda.  Population growth has been spiraling downward for several years in America but reached historic lows during the peak of the Covid mRNA jab campaign.

Birth rates and fertility have steadily declined as death rates have increased.

Adding to this trend, we now know alarming statistics of fetal and baby mortality from mothers who received Covid jabs, as well as proven harms to male fertility, based on thousands of Pfizer documents released to the public.

Countries around the globe are reporting dramatic declines in birth rates including Germany, UK, Switzerland, Taiwan, Sweden, Hungary, the Netherlands and China.

As the global population declines due, in-part, to adverse events from the mRNA injections affecting birth and fertility, scientists backed by multimillions in funding have been working feverishly to advance artificial womb technology.

Recent Artificial Womb Advancements

The concept of artificial wombs may seem like science fiction straight from the dystopian novel Brave New World, but advancements in recent years are making this technology a reality.  Though many experiments using artificial wombs in the past have failed, recent research has been much more successful.

In 2017, researchers at the Children’s Hospital of Philadelphia (CHOP) successfully developed extremely premature lambs within artificial uterus environments.  Researchers placed eight lambs in artificial uteruses from a gestation stage equivalent to a human baby’s development in the womb during weeks 23 and 24.

The lambs were kept in the artificial wombs for four weeks while their brains and lungs matured.  “If we can develop an extra-uterine system to support growth and organ maturation for only a few weeks, we can dramatically improve outcomes for extremely premature babies,” noted Senior Researcher, Alan Flake. 

The researchers planned to test the device on premature human babies this year.

Improving the health of premature infants by means of artificial wombs is not the sole objective for CHOP, as the hospital has recently come into the spotlight for allegedly providing puberty blockers to children as young as 8 years old as well as sex reassignment surgeries to children around 14 years of age.

Since 2018, geneticist George Church, has focused on resurrecting the extinct woolly mammoth to solve – you guessed it – ‘climate change’!

In September of 2021, George Church and technology entrepreneur, Ben Lamm, co-founded Colossal Biosciences backed by $75 million in funding, to revive genetically modified hybrids of extinct species such as the woolly mammoth.

The de-extinction project involves combining woolly mammoth and Asian elephant DNA using CRISPR technology, then developing the genetically modified embryos to full term via artificial wombs.  Since finding the right surrogates to carry the genetically modified embryos for 22 months is a challenge, the team is leaning towards the use of artificial uteruses.  The group is on target to produce the first genetically modified woolly mammoth hybrid calf by 2027.

When asked during a July 2022 interview if the technology developed through the de-extinction project could be applied to humans, Church explained, “If the artificial womb works out, then that might be beneficial in certain cases in humans, but we wouldn’t want to develop that in humans because there’s a lot of ‘debugging’ that would not be ideal to do in humans. You would want to do it in animals first.”

In a 2013 interview, Church opined on the potential use of genetic engineering to resurrect extinct Neanderthals.  While acknowledging the legal and ethical challenges to such a venture, Church quickly added that, “laws can change.”  However, Church does not seem overly concerned about the ethical dilemmas of his research, as the Harvard geneticist was eager to accept Jeffrey Epstein’s funding as well as collaborate with the Chinese company, BGI, which has been suspected of using Covid tests as a means to collect genetic information on Americans.

When co-founder Ben Lamm was asked during a September 2022 interview about the monetization potential of technologies developed through the de-extinction project he remarked:

“Part of our two-pronged monetization plan is taking technologies on the path to de-extinction, whether that’s software –  which happens on the computer, wetware – which happens in the lab, or hardware – in the case of like artificial wombs or other robotics for labs…

and then apply that to human healthcare… Even just one technology out of this is billions of dollars of economic value.”

Investing multimillions into reviving genetically modified woolly mammoths – as an answer to ‘climate change’ – may seem like a ridiculous venture until you realize there’s billions to be made in the human applications of genetic and artificial womb technologies developed by the project.

In October of 2019, Eindhoven University of Technology was awarded a 2.9 million euro grant by the Horizon 2020 EU program for the development of an artificial womb prototype to provide life support for babies who are born extremely premature.

Participants in the project aim to use simulation technology and manakins to mimic the premature babies while testing their perinatal life support system.  The researchers plan to complete a proof-of-principle working prototype by 2024, with the goal of their artificial wombs in use in hospitals by 2030.

There’s that deadline again – 2030!

“It does sound a bit like science fiction.  But we won’t be doing anything illegal or advised against.  Within the limits of current legislation, we’re improving neonatal care,” remarked Jasmijn Kok, who is the co-founder of Juno Perinatal Healthcare, a start-up partnered with the project.

Though it does appear the project has taken measures to ensure the technology is adequately tested before it reaches human clinical trials, the statement, “we won’t be doing anything illegal,” doesn’t exactly instill confidence.

In March of 2021, Israeli scientists announced a breakthrough in using artificial womb technology to develop hundreds of mouse embryos into fetuses with fully formed organs.  Though the mice died by the eleventh day, the researchers plan to develop the technology further in order to bring them to full term.

The top researcher on the project who is a stem cell biologist, Prof. Jacob Hanna, stated, “This could be relevant to other mammals including humans, though we acknowledge that there are ethical issues related to growing humans outside the body.”

However, Hanna went on to say in a separate interview that he believes, if the international guidelines were amended, the Israeli ethics board would sign off on further research of his artificial womb using human embryos beyond the long-held international rule limiting lab-grown embryos to a maximum of 14 days.

He remarked, “Once the guidelines are updated, I can apply, and it will be approved.  It’s a very important experiment,” adding, “We need to see human embryos gastrulate and form organs and start perturbing it.  The benefit of growing human embryos to week three, week four, week five is invaluable.  I think those experiments should at least be considered.  If we can get an advanced human embryo, we can learn so much.”

Week three, week four, week five… full term?  Where does it end?  Rapid developments in this technology are pushing the envelope on legal and ethical standards for human embryo experimentation.

In May of 2021, as predicted, a governing body over the practices of human embryo research, The International Society for Stem Cell Research (ISSCR), made “the most striking” change to their updated guidelines by “relaxing” the long-standing 14-day rule, whereby lab grown human embryos must be destroyed.

By relaxing the 14-day international guideline established over 40 years ago, which has become law in some countries, the ISSCR sent a critical message to lawmakers and the scientific community, that certain scientific research conducted on human embryos beyond the 14-day limit is no longer considered unethical.

As a result of these newly relaxed international guidelines, one can only imagine the kinds of research that may be conducted on human embryos beyond the 14-day mark in secretive nations – like China.

In January of 2022, just months after this significant change to the international standards of human embryo research by the ISSCR, Chinese scientists announced that they have developed an AI robot capable of monitoring embryos as they develop inside artificial wombs.

The AI robot can identify the embryos’ needs and adjust their environment, nutrition, and carbon dioxide levels accordingly.  The researchers claim that their AI monitoring artificial womb system is even more safe and efficient than a mother’s womb, that their system could help solve birth defects – by discarding embryos with major deficiencies, and that the AI robot is capable of even ranking the human embryos according to their development potential.

Advancements such as this may provide a slippery slope towards eugenics.

The obstacles this Chinese artificial womb system faces are of the legal and ethical sort, rather than technological. The study explains that more research on the later stages of human embryo development is essential.  Fortunately for these researchers, the ISSCR has helped pave the way for human embryo research beyond 14 days!

China may have an incentive to develop this artificial womb system further, as their birth rates fell for a fifth year in a row to new record lows.

Ethical Implications

Artificial womb technology used as life support for extremely premature babies could make a tremendous impact on saving precious lives and could potentially shatter previous concepts of the term ‘viability.’  At some point in the near future, all stages of fetal development may be considered ‘viable’ with the use of an artificial womb, impacting any abortion laws that rely on viability.  In cases of unwanted pregnancies, artificial wombs may someday replace abortion all-together.

On the other hand, this technology could redefine fundamental values of traditional families and motherhood.  At some point, artificial wombs may enable non-traditional families, including LGBTQ+ parents, to have babies without the help of surrogate mothers.  Even biological women may choose to forego the natural process of pregnancy and delivery in exchange for the use of artificial wombs.

Furthermore, advancements in gene editing as well as early detection of diseases and defects may be used in conjunction with artificial wombs to create a slippery slope towards eugenics, by which ‘imperfect’ human embryos are carelessly discarded in the pursuit of the ‘perfect’ human being.

By far, the most disturbing possibility for this technology is its potential use in conjunction with mass sterilization of the population, which could enable authoritarian regimes to have a monopoly on the production of future generations.

As countries around the globe report dramatic declines in birth rates and fertility, one could speculate this agenda is beginning to unfold. 

Legal Challenges

Recent advancements in this technology, coupled with updates to the international guidelines for human embryo research, are pushing the envelope on legal and ethical roadblocks.  Based on the White House Executive Order on Advancing Biotechnology and Biomanufacturing, the Biden regime seems motivated to remove ethical and legal obstacles hindering advancements in this field.

The EO states:

“We need to develop genetic engineering technologies and techniques to be able to write circuitry for cells and predictably program biology in the same way in which we write software and program computers; unlock the power of biological data, including through computing tools and artificial intelligence; and advance the science of scale‑up production while reducing the obstacles for commercialization so that innovative technologies and products can reach markets faster.”

Lawmakers must act quickly to strengthen protections against unethical human embryo research to catch up with scientific advancements.

A study in the Journal of Law and the Biosciences notes that, “While the federal government holds significant influence over biomedical research policy, US state policies play an important role delimiting research into early human development since there are currently no existing federal laws specifically permitting or prohibiting human embryo or embryoid research,” adding, “The USA has developed over time a complicated patchwork of state laws.”

The study finds that 29 states have laws impacting human embryo research.  Eleven of those states have banned it, while most states permit human embryo and embryoid research either directly by law or by absence of laws restricting it.

Final Thoughts

As global birth and fertility rates dramatically decline, artificial womb research is rapidly advancing. Artificial wombs could be both a blessing and a curse.  In the right hands this technology could be used to save precious premature babies, while in the wrong hands it could be used as a tool for eugenics and population control.

Legal and ethical standards are the final hurdle for developing this technology further.  But recent changes to international guidelines may pave the way for more research in this field using human embryos.

Lawmakers in most states have failed to keep up with the expanding human embryo research that, in the pursuit of ‘science,’ is always pushing the envelope. Meanwhile, the Biden regime’s transhumanist EO has placed focus on reducing obstacles to rush technologies such as this to market.

As researchers develop the technology to make this dystopian vision a reality, few dissenting voices are asking the most pressing question – should we?

See more here coreysdigs.com

Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.